Drugs / TB/FLU-01L
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03017378 Comparator | Oct 2013 → Apr 2014 | tuberculosis | Research Institute for Biological Safety Problems | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TB/FLU-01L | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03017378 ↗ |
| Modality | Vaccine | “2 doses (Day 1 and Day 21) TB/FLU-01L tuberculosis vaccine” NCT03017378 ↗ |
| Route | Other | “TB / FLU-01L (intranasal application)” NCT03017378 ↗ |